No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma

Authors

• Tristan E. Knight, Seattle Children's Hospital, Seattle, WA
• Kwang Woo Ahn, Medical College of Wisconsin, Milwaukee, WI
• Kyle M. Hebert, Medical College of Wisconsin, Milwaukee, WI
• Rasha Atshan, Medical College of Wisconsin, Milwaukee, WI
• Donna A. Wall, University of Toronto, Toronto, ON
• Kanhatai Chiengthong, Chulalongkorn University, Bangkok, Thailand
• Troy C. Lund, University of Minnesota, Minneapolis, MN
• Tim Prestidge, Starship Children's Hospital, Auckland, New Zealand
• Hemalatha G. Rangarajan, Nationwide Children's Hospital, Columbus, OH
• Christopher C. Dvorak, University of California San Francisco, San Francisco, CA
• Jeffery J. Auletta, National Marrow Donor Program/Be The Match, Minneapolis, MN
• Michael Kent, Atrium Health Levine Children's, Charlotte, NC
• Hasan Hashem, King Hussein Cancer Center, Amman, Jordan
• Julie-An Talano, Medical College of Wisconsin, Milwaukee, WI
• Seth J. Rotz, Cleveland Clinic, Cleveland, OH
• Ellen Fraint, The Children's Hospital at Montefiore, Bronx, NY
• Kasiani C. Myers, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
• Wing Leung, Duke-NUS Medical School, Singapore, Singapore
• Akshay Sharma, St. Jude Children's Research Hospital, Memphis, TN
• Neel S. Bhatt, University of Washington School of Medicine, Seattle, WA
• Timothy A. Driscoll, Duke University Pediatric Transplantation and Cellular Therapy, Durham, NC
• Lolie C. Yu, LSU Health Sciences Center - New OrleansFollow
• Kirk R. Schultz, The University of British Columbia, Vancouver, BC, Canada
• Muna Qayed, Emory University and Children's Healthcare of Atlanta, Atlanta, GA
• Larisa Broglie, Medical College of Wisconsin, Milwaukee, WI
• Mary Eapen, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
• Gregory A. Yanik, University of Michigan Medical Center, Ann Arbor, MI

Document Type

Letter to the Editor

Publication Date

9-4-2023

Publication Title

Bone Marrow Transplantation

First Page

1390

Last Page

1393

PubMed ID

37666957

Volume

58

Issue

12

Recommended Citation

Knight, Tristan E.; Ahn, Kwang Woo; Hebert, Kyle M.; Atshan, Rasha; Wall, Donna A.; Chiengthong, Kanhatai; Lund, Troy C.; Prestidge, Tim; Rangarajan, Hemalatha G.; Dvorak, Christopher C.; Auletta, Jeffery J.; Kent, Michael; Hashem, Hasan; Talano, Julie-An; Rotz, Seth J.; Fraint, Ellen; Myers, Kasiani C.; Leung, Wing; Sharma, Akshay; Bhatt, Neel S.; Driscoll, Timothy A.; Yu, Lolie C.; Schultz, Kirk R.; Qayed, Muna; Broglie, Larisa; Eapen, Mary; and Yanik, Gregory A., "No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma" (2023). School of Medicine Faculty Publications. 2142.
https://digitalscholar.lsuhsc.edu/som_facpubs/2142
10.1038/s41409-023-02092-3